Market capitalization | $85.83b |
Enterprise Value | $154.51b |
P/E (TTM) P/E ratio | 16.21 |
EV/FCF (TTM) EV/FCF | 26.01 |
EV/Sales (TTM) EV/Sales | 0.41 |
P/S ratio (TTM) P/S ratio | 0.23 |
P/B ratio (TTM) P/B ratio | 1.11 |
Dividend yield | 3.92% |
Last dividend (FY24) | $2.66 |
As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.
30 Analysts have issued a CVS Health forecast:
30 Analysts have issued a CVS Health forecast:
Mar '25 |
+/-
%
|
||
Revenue | 378,846 378,846 |
5%
5%
|
|
Gross Profit | 53,122 53,122 |
2%
2%
|
|
EBITDA | 16,159 16,159 |
13%
13%
|
EBIT (Operating Income) EBIT | 11,546 11,546 |
18%
18%
|
Net Profit | 5,280 5,280 |
28%
28%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Head office | United States |
CEO | J. Joyner |
Employees | 300,000 |
Founded | 1963 |
Website | www.cvshealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.